Molecular Imaging 2017

Summary

 MRI preferred to CT where greater tissue contrast is required, or where no contrast agent administered  Response criteria allow standardised reporting in clinical trials but have limitations  Physiological sequences may be helpful in Phase I trials to demonstrate biological effect e.g. anti- vascular  MRI has a role in response assessment in the clinical pathway